SIMEPREVIR SODIUM - Generic Drug Details
✉ Email this page to a colleague
What are the generic drug sources for simeprevir sodium and what is the scope of patent protection?
Simeprevir sodium
is the generic ingredient in one branded drug marketed by Janssen Prods and is included in one NDA. There are nine patents protecting this compound. Additional information is available in the individual branded drug profile pages.Simeprevir sodium has one hundred and thirty-nine patent family members in forty-three countries.
Summary for SIMEPREVIR SODIUM
International Patents: | 139 |
US Patents: | 9 |
Tradenames: | 1 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 46 |
Patent Applications: | 1,708 |
DailyMed Link: | SIMEPREVIR SODIUM at DailyMed |
DrugPatentWatch® Estimated Loss of Exclusivity (LOE) Date for SIMEPREVIR SODIUM
Generic Entry Date for SIMEPREVIR SODIUM*:
Constraining patent/regulatory exclusivity:
Dosage:
CAPSULE;ORAL |
*The generic entry opportunity date is the latter of the last compound-claiming patent and the last regulatory exclusivity protection. Many factors can influence early or later generic entry. This date is provided as a rough estimate of generic entry potential and should not be used as an independent source.
Medical Subject Heading (MeSH) Categories for SIMEPREVIR SODIUM
US Patents and Regulatory Information for SIMEPREVIR SODIUM
International Patents for SIMEPREVIR SODIUM
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Norway | 341392 | ⤷ Try a Trial | |
Slovenia | 1713823 | ⤷ Try a Trial | |
Japan | 2011140488 | HCV NS-3 SERINE PROTEASE INHIBITOR | ⤷ Try a Trial |
Hungary | S1400054 | ⤷ Try a Trial | |
Brazil | PI0506948 | inibidores de serina protease ns-3 de hcv | ⤷ Try a Trial |
Ukraine | 84050 | ІНГІБІТОРИ СЕРИН-ПРОТЕАЗИ NS-3 HCV[ИНГИБИТОРЫ СЕРИН-ПРОТЕАЗЫ NS-3 HCV (HCV NS-3-SERINE PROTEASE INHIBITORS) | ⤷ Try a Trial |
Denmark | 1713823 | ⤷ Try a Trial | |
>Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for SIMEPREVIR SODIUM
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
1912999 | 2014/058 | Ireland | ⤷ Try a Trial | PRODUCT NAME: SIMEPREVIR, OR A SALT THEREOF, INCLUDING SIMEPREVIR SODIUM; REGISTRATION NO/DATE: EU/1/14/924/001-002 20140516 |
1912999 | PA2014036,C1912999 | Lithuania | ⤷ Try a Trial | PRODUCT NAME: SIMEPREVIRAS; REGISTRATION NO/DATE: EU/1/14/924 20140514 |
1912999 | PA2014036 | Lithuania | ⤷ Try a Trial | PRODUCT NAME: SIMEPREVIRUM; REGISTRATION NO/DATE: EU/1/14/924 20140514 |
1912999 | C01912999/01 | Switzerland | ⤷ Try a Trial | PRODUCT NAME: SIMEPREVIR; REGISTRATION NO/DATE: SWISSMEDIC 63215 04.03.2015 |
1713823 | CR 2014 00059 | Denmark | ⤷ Try a Trial | PRODUCT NAME: SIMEPREVIR ELLER ET FARMACEUTISK SALT DERAF, HERUNDER SIMEPREVIRNATRIUM; REG. NO/DATE: EU/1/14/924 20140516 |
1713823 | 132014902308868 | Italy | ⤷ Try a Trial | PRODUCT NAME: SIMEPREVIR O UN SUO SALE FARMACEUTICAMENTE ACCETTABILE, COMPRESO IL SALE SODICO(OLYSIO); AUTHORISATION NUMBER(S) AND DATE(S): EU/1/14/924, 20140516 |
1912999 | 132014902299482 | Italy | ⤷ Try a Trial | PRODUCT NAME: SIMEPREVIR O UN SUO SALE, COMPESO IL SALE SODICO(OLYSIO); AUTHORISATION NUMBER(S) AND DATE(S): EU/1/14/924, 20140516 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |